iShares Genomics Immunology and Healthcare ETF
IDNA
IDNA
48 hedge funds and large institutions have $44.4M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Holders
48
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.99M | |
| 2 | +$1.54M | |
| 3 | +$1.32M | |
| 4 |
Morgan Stanley
New York
|
+$333K |
| 5 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$304K |
Top Sellers
| 1 | -$2.13M | |
| 2 | -$1.16M | |
| 3 | -$721K | |
| 4 |
Jane Street
New York
|
-$662K |
| 5 |
LWM
Laidlaw Wealth Management
New York City,
New York
|
-$477K |
